Concepedia

Alex Aliper

AA

Statistics

Publications

37

Citations

4.5K

H-Index

24

Active since

2015

Affiliations

Insilicos (United States)(Current)

Hong Kong Science and Technology Parks Corporation

Insilico Medicine (United States)

Buck Institute for Research on Aging

Moscow Institute of Physics and Technology

Alex Aliper is an author at Insilicos (United States) specializing in drug discovery, drug design, and pharmacy.

Publications per year

2015–2025

37

Publications

37

Deep learning enables rapid identification of potent DDR1 kinase inhibitors

Alex Zhavoronkov, Yan A. Ivanenkov, Alex Aliper et al. · Nature Biotechnology · 2019 · 1.5K citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico

Artur Kadurin, Sergey Nikolenko, Kuzma Khrabrov et al. · Molecular Pharmaceutics · 2017 · 614 citations

Pharmacy, Medicinal Chemistry, Drug Design +15

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor

Feng Ren, Xiao Ding, Min Zheng et al. · Chemical Science · 2023 · 326 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +8

A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models

Feng Ren, Alex Aliper, Jian Chen et al. · Nature Biotechnology · 2024 · 270 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Human Gut Microbiome Aging Clock Based on Taxonomic Profiling and Deep Learning

Fedor Galkin, Polina Mamoshina, Alex Aliper et al. · iScience · 2020 · 233 citations · Full text

Life Sciences, Biology, Microbiology +17

1–5 of 37